SMTL ID : 8q6j.1

Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-1-mer

Ligands

2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 2 residues within 4Å: Chain E: D.163, N.165 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.2: 5 residues within 4Å: Chain E: C.230, L.231, N.237, S.239, G.240 No protein-ligand interaction detected (PLIP)

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 2 residues within 4Å: Chain E: T.45, N.46 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:T.45 NAG.4: 2 residues within 4Å: Chain E: R.495, N.508 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:R.495 NAG.5: 4 residues within 4Å: Chain E: Q.546, P.547, Q.548, N.549 3 PLIP interactions: 3 interactions with chain E Hydrophobic interactions: E:Q.548 Hydrogen bonds: E:Q.546, E:N.549

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ruedas, R. et al., Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex. To Be Published

Release Date

2023-09-20

Peptides

Trastuzumab fab light chain: A
Trastuzumab Fab heavy chain: B
Pertuzumab Fab light chain: C
Pertuzumab Fab heavy chain: D
Receptor tyrosine-protein kinase erbB-2: E

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

Trastuzumab fab light chain

Trastuzumab Fab heavy chain

Pertuzumab Fab light chain

Pertuzumab Fab heavy chain

Receptor tyrosine-protein kinase erbB-2

Related Entries With Identical Sequence